|
|
Volumn 3, Issue 9, 2011, Pages 935-938
|
|
How to manage having no incurred sample reanalysis evaluation failures.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
ARTIFACT;
BIOAVAILABILITY;
BIOTRANSFORMATION;
CHEMICAL ANALYSIS;
DRUG STABILITY;
EDITORIAL;
HUMAN;
LABORATORY DIAGNOSIS;
PHARMACOKINETICS;
PRACTICE GUIDELINE;
STANDARD;
VALIDATION STUDY;
ARTIFACTS;
BIOLOGICAL AVAILABILITY;
BIOLOGICAL PRODUCTS;
BIOTRANSFORMATION;
CHEMISTRY TECHNIQUES, ANALYTICAL;
DRUG STABILITY;
GUIDELINE ADHERENCE;
GUIDELINES AS TOPIC;
HUMANS;
SPECIMEN HANDLING;
THERAPEUTIC EQUIVALENCY;
VALIDATION STUDIES AS TOPIC;
|
|
EID: 80052548978
PISSN: None
EISSN: 17576199
Source Type: Journal
DOI: 10.4155/bio.11.22 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
